1. Mayr N, Baumgartner C, Zeitlhofer J, Deecke Ld. The sensitivity of transcranial cortical magnetic stimulation in detecting pyramidal tract lesions in clinically definite multiple sclerosis. Neurology. 1991; 41(4): 566-569. [DOI:10.1212/WNL.41.4.566]

2. Bizzoco E, Lolli F, Repice AM, Hakiki B, Falcini M, Barilaro A, et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. Journal of neurology. 2009; 256: 1891-8. [DOI:10.1007/s00415-009-5171-x]

3. Ryan M, Piascik P. Providing pharmaceutical care to the multiple sclerosis patient. Journal of the American Pharmaceutical Association (1996). 2002; 42(5): 753-67. [DOI:10.1331/108658002764653531]

4. García-Muñoz C, Cortés-Vega M-D, Heredia-Rizo AM, Martín-Valero R, García-Bernal M-I, Casuso-Holgado MJ. Effectiveness of vestibular training for balance and dizziness rehabilitation in people with multiple sclerosis: a systematic review and meta-analysis. Journal of clinical medicine. 2020; 9(2): 590. [DOI:10.3390/jcm9020590]

5. Kantarci O, Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Current opinion in neurology. 2006; 3(9): 248-54. [DOI:10.1097/01.wco.0000227033.47458.82]

6. Döring A, Pfueller CF, Paul F, Dörr J. Exercise in multiple sclerosis--an integral component of disease management. Epma journal. 2012; 3:1-13. [DOI:10.1007/s13167-011-0136-4]

7. McCabe MP. Mood and self-esteem of persons with multiple sclerosis following an exacerbation. Journal of psychosomatic research. 2005; 59(3): 161-6. [DOI:10.1016/j.jpsychores.2005.04.010]

8. Li Y. Multiple sclerosis and other demyelinating diseases. Imaging of CNS Infections and Neuroimmunology. 2019: 155-64. [DOI:10.1007/978-981-13-6904-9_15]

9. Nair A, Frederick TJ, Miller SD. Astrocytes in multiple sclerosis: a product of their environment. Cellular and molecular life sciences. 2008; 65: 2702-20. [DOI:10.1007/s00018-008-8059-5]

10. Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. Journal of neurology.2004; 8: 251-261. [DOI:10.1007/s00415-004-0348-9]

11. Gonsette R. Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? Multiple Sclerosis Journal. 2008; 14(1): 22-34. [DOI:10.1177/1352458507080111]

12. Zhang J-M, An J. Cytokines, inflammation, and pain. International anesthesiology clinics. 2007; 45(2): 27-37. [DOI:10.1097/AIA.0b013e318034194e]

13. Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacology & therapeutics. 2005; 106(2): 163-77. [DOI:10.1016/j.pharmthera.2004.11.007]

14. Hirano T, Kishimoto T. Interleukin-6. Peptide growth factors and their receptors I. 1991: 633-65-75. [DOI:10.1007/978-1-4612-3210-0_14]

15. Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane database of systematic reviews. 2005; 1. [DOI:10.1002/14651858.CD003980.pub2]

16. Brück W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. Journal of neurology. 2005; 252: 3-9. [DOI:10.1007/s00415-005-5002-7]

17. Ryba-Stanisławowska M, Skrzypkowska M, Myśliwska J, Myśliwiec M. The serum IL‐6 profile and Treg/Th17 peripheral cell populations in patients with type 1 diabetes. Mediators of inflammation. 2013; (1): 205-284. [DOI:10.1155/2013/205284]

18. Chen Y-C, Yang X, Miao L, Liu Z-G, Li W, Zhao Z-X, et al. Serum level of interleukin-6 in Chinese patients with multiple sclerosis. Journal of neuroimmunology. 2012; 249(1-2): 109-11. [DOI:10.1016/j.jneuroim.2012.04.015]

19. Stelmasiak Z, Kozioł-Montewka M, Dobosz B, Rejdak K, Bartosik-Psujek H, Mitosek-Szewczyk K, et al. Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients. Medical science monitor: international medical journal of experimental and clinical research. 2000; 6(6): 1104-8.

20. Gil-González I, Martín-Rodríguez A, Conrad R, Pérez-San-Gregorio MÁ. Quality of life in adults with multiple sclerosis: a systematic review. BMJ open. 2020; 10(11): e041249. [DOI:10.1136/bmjopen-2020-041249]

21. Maghbooli M, Nejhadalirezayi A, Mazloomzadeh S. Social support in patients with multiple sclerosis: a cross-sectional study. The Neuroscience Journal of Shefaye Khatam. 2022; 11(1): 37-45. [DOI:10.52547/shefa.11.1.37]

22. Habibi S, Abdi A, Fazelifar S. the effect of aerobic training and resveratrol on ferroptosis in a rat model of Alzheimer's disease. The Neuroscience Journal of Shefaye Khatam. 2023; 11(4): 1-11. [DOI:10.61186/shefa.11.4.1]

23. Faramarzi M, Banitalebi E, Raisi Z, Samieyan M, Saberi Z, Ghahfarrokhi MM, et al. Effect of combined exercise training on pentraxins and pro-inflammatory cytokines in people with multiple sclerosis as a function of disability status. Cytokine. 2020; 134: 155196. [DOI:10.1016/j.cyto.2020.155196]

24. Rezaee S, Kahrizi S, Nabavi SM, Hedayati M. Vegf and tnf-α responses to acute and chronic aerobic exercise in the patients with multiple sclerosis. Asian Journal of Sports Medicine. 2020; 1(3). [DOI:10.5812/asjsm.98312]

25. White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sports medicine. 2004; 34: 1077-100. [DOI:10.2165/00007256-200434150-00005]

26. Miri M, Tahami E, Veisi G. Improving muscle strength and neuroplasticity in multiple sclerosis patients: Combined effects of electromyographic biofeedback, isometric exercises and EEG monitoring. The Neuroscience Journal of Shefaye Khatam. 2025; 13(3): 12-25. [DOI:10.61882/shefa.13.3.12]

27. Dean E, Al-Obaidi S, De Andrade A. Introduction (References).

28. Kajkolah M, Nahumi A, Asgari A, Bayrami A, Abdolmaleki A. Protective Effects of Saffron in Nervous System Diseases: A Narrative Review. The Neuroscience Journal of Shefaye Khatam. 2024; 12(2): 74-86. [DOI:10.61186/shefa.12.2.74]

29. Kajkolah M, Mousavi F, Asgari A, Asadi A, Abdolmaleki A. Evaluation of Neuropharmacological Effects of Ginger: A Narrative Review. The Neuroscience Journal of Shefaye Khatam. 2022; 10(3): 113-22. [DOI:10.52547/shefa.10.3.113]

30. Lucas L, Russell A, Keast R. Molecular mechanisms of inflammation. Anti-inflammatory benefits of virgin olive oil and the phenolic compound oleocanthal. Current pharmaceutical design. 2011; 17(8): 754-68. [DOI:10.2174/138161211795428911]

31. Sanchez-Rodriguez E, Biel-Glesson S, Fernandez-Navarro JR, Calleja MA, Espejo-Calvo JA, Gil-Extremera B, et al. Effects of virgin olive oils differing in their bioactive compound contents on biomarkers of oxidative stress and inflammation in healthy adults: A randomized double-blind controlled trial. Nutrients. 2019; 11(3): 561. [DOI:10.3390/nu11030561]

32. Psaltopoulou T, Kosti RI, Haidopoulos D, Dimopoulos M, Panagiotakos DB. Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13800 patients and 23340 controls in 19 observational studies. Lipids in health and disease. 2011; 10: 1-16. [DOI:10.1186/1476-511X-10-127]

33. Basu A, Schell J, Scofield RH. Dietary fruits and arthritis. Food & function. 2018; 9(1): 70-7. [DOI:10.1039/C7FO01435J]

34. Yarla NS, Polito A, Peluso I. Effects of Olive Oil on TNF-α and IL-6 in Humans: Implication in Obesity and Frailty. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders). 2018; 18(1): 63-74. [DOI:10.2174/1871530317666171120150329]

35. Jiménez-Sánchez A, Martínez-Ortega AJ, Remón-Ruiz PJ, Piñar-Gutiérrez A, Pereira-Cunill JL, García-Luna PP. Therapeutic properties and use of extra virgin olive oil in clinical nutrition: A narrative review and literature update. Nutrients. 2022; 14(7): 1440. [DOI:10.3390/nu14071440]

36. Siahpoosh A, Majdinasab N, Derakhshannezhad N, Khalili HR, Malayeri A. Effect of grape seed on quality of life in multiple sclerosis patients. Journal of Contemporary Medical Sciences. 2018; 4(3).

37. Khandouzi N, Zahedmehr A, Nasrollahzadeh J. Effect of polyphenol-rich extra-virgin olive oil on lipid profile and inflammatory biomarkers in patients undergoing coronary angiography: A randomised, controlled, clinical trial. International journal of food sciences and nutrition. 2021; 72(4): 548-58. [DOI:10.1080/09637486.2020.1841123]

38. DeBolt LS, McCubbin JA. The effects of home-based resistance exercise on balance, power, and mobility in adults with multiple sclerosis. Archives of physical medicine and rehabilitation. 2004; 85(2): 290-7. [DOI:10.1016/j.apmr.2003.06.003]

39. Jalili Sarqaleh A, Azizi M, Khamoshyan K. The effect of eight weeks of home based combined training with red grape juice supplementation on quality of life in women with multiple sclerosis. Payavard Salamat. 2022; 16(1): 49-60.

40. Bruno A, Dolcetti E, Azzolini F, Moscatelli A, Gambardella S, Ferese R, et al. Interleukin 6 SNP rs1818879 regulates radiological and inflammatory activity in multiple sclerosis. Genes. 2022; 13(5): 897. [DOI:10.3390/genes13050897]

41. Shobeiri P, Seyedmirzaei H, Karimi N, Rashidi F, Teixeira AL, Brand S, et al. IL-6 and TNF-α responses to acute and regular exercise in adult individuals with multiple sclerosis (MS): a systematic review and meta-analysis. European Journal of Medical Research. 2022; 27(1): 185. [DOI:10.1186/s40001-022-00814-9]

42. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. The Lancet Neurology. 2010; 9(7): 727-39. [DOI:10.1016/S1474-4422(10)70094-6]

43. Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. The Lancet Neurology. 2015; 14(4): 406-19. [DOI:10.1016/S1474-4422(14)70305-9]

44. Pedersen BK. Anti‐inflammatory effects of exercise: role in diabetes and cardiovascular disease. European Journal of Clinical Investigation. 2017; 47(8): 600-11. [DOI:10.1111/eci.12781]

45. Gorzynik-Debicka M, Przychodzen P, Cappello F, Kuban-Jankowska A, Marino Gammazza A, Knap N, et al. Potential health benefits of olive oil and plant polyphenols. International Journal of Molecular Sciences. 2018; 19(3): 686. [DOI:10.3390/ijms19030686]

46. Flores VA, Šilić P, DuBose NG, Zheng P, Jeng B, Motl RW. Effects of aerobic, resistance, and combined exercise training on health-related quality of life in multiple sclerosis: Systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. 2023; 75: 104746. [DOI:10.1016/j.msard.2023.104746]

47. Beratto L, Bressy L, Agostino S, Malandrone F, Brichetto G, Ponzano M. The effect of exercise on mental health and health-related quality of life in individuals with multiple sclerosis: A Systematic review and meta-analysis. Multiple Sclerosis and Related Disorders. 2024; 83: 105473. [DOI:10.1016/j.msard.2024.105473]

48. Gitman V, Moss K, Hodgson D. A systematic review and meta-analysis of the effects of non-pharmacological interventions on quality of life in adults with multiple sclerosis. European Journal of Medical Research. 2023; 28(1): 294. [DOI:10.1186/s40001-023-01185-5]

49. Dalgas U, Langeskov-Christensen M, Stenager E, Riemenschneider M, Hvid LG. Exercise as medicine in multiple sclerosis-time for a paradigm shift: preventive, symptomatic, and disease-modifying aspects and perspectives. Curr Neurol Neurosci Rep. 2019; 19(11): 88. [DOI:10.1007/s11910-019-1002-3]